New Approaches to Investigate Novel Agents in Ewing Sarcoma: A Report From the Children's Oncology Group Bone Tumor Committee
Jessica D. Daley(University of Pittsburgh), Kelly M. Bailey(University of Pittsburgh), Elizabeth R. Lawlor(Center for Infectious Disease Research), Sarah Cohen‐Gogo(Hospital for Sick Children), Alice Soragni(California NanoSystems Institute), Patrick J. Grohar(National Institutes of Health), Sarah Burkhead Whittle(Baylor College of Medicine), Damon R. Reed(Memorial Sloan Kettering Cancer Center), Ajay Gupta(Roswell Park Comprehensive Cancer Center), Joyce E. Ohm(Roswell Park Comprehensive Cancer Center), Katherine A. Janeway(Harvard University), Filemon S. Dela Cruz, Anderson B. Collier, Bhuvana A. Setty(Nationwide Children's Hospital), Susan L. Whiteway(Uniformed Services University of the Health Sciences), Emily K. Slotkin(Memorial Sloan Kettering Cancer Center), Andrew Clark(ViiV Healthcare (Spain)), Christine M. Heske(National Institutes of Health)
Cited by 6
Related Papers
Organoids
|Nature Reviews Methods Primers|2022|903
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
|European Journal of Cancer|2019|724
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
|The Lancet Oncology|2016|537